Science
Mechanism of Action
Crotamiton's antipruritic efficacy stems from its ability to inhibit the transient receptor potential vanilloid 4 (TRPV4) ion channel within sensory neurons, which blocks calcium influx and thereby reduces the transmission of itch signals, independent of antihistamine or corticosteroid pathways. Additionally, it may induce a counter-irritant cooling sensation upon evaporation. For its scabicidal properties, Crotamiton kills adult mites and larvae by disrupting their nervous and muscular systems, although its precise mechanism against mites is not fully elucidated.
Research
Clinical Evidence
Medium confidence10%
Key findings
- 01 A 10% concentration is clinically used in cream or lotion formulations for scabies treatment, typically applied twice within 24 hours. Efficacy as a scabicide has been noted as variable, often lower than permethrin, and may necessitate re-treatment.
- 02 For symptomatic relief of pruritus, a 10% cream is applied topically to affected areas. Studies demonstrate a concentration-dependent inhibitory effect on histamine-induced itch pathways in sensory neurons, with an IC50 of 101.2 µM.
- 03 Topical application of 10% Crotamiton (5g) leads to rapid systemic absorption, though plasma concentrations remain low, reaching a mean maximum of 24.5 ng/ml after approximately 7 hours without significant accumulation upon repeated daily applications.
Transparency
Dusting Analysis
Crotamiton is a potent, prescription-only medication in the US, used at a specific 10% concentration for therapeutic purposes. Its regulatory status and targeted actions preclude its casual inclusion or 'dusting' in general cosmetic formulations.
The Formula
Formulation
Stability
Crotamiton should be stored between 15-30 °C, away from freezing and direct light. It is miscible with alcohol and methanol but exhibits sparing solubility in aqueous buffers. For incorporation into aqueous systems, it requires prior dissolution in DMSO before dilution.
Conflicts
- Severely inflamed skin
- Raw oozing areas of the skin
- Mucous membranes
- Eyes
- Urethral meatus
- Face
Safety
Safety Profile
Approved by the U.S. FDA in 1949, Crotamiton is classified as a prescription-only medication. Common side effects (1-10% incidence) include localized skin reactions such as erythema, itching, or a burning sensation. Rarely, mild allergic contact dermatitis has been reported. It is contraindicated on acutely inflamed, raw, or weeping skin, and contact with sensitive areas like eyes, mucous membranes, and the face must be avoided. It is classified as Pregnancy Category C.
Your Skin
Skin Compatibility
Our Assessment
Verdict
As a prescription-only drug with potential for skin irritation and specific contraindications, Crotamiton is not suitable for general cosmetic formulations within a precision skincare brand, despite its effective antipruritic properties.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources